Healio

VIDEO: ANA presentations focus on AI, gene-based therapies

Please provide your email address to receive an email when new articles are posted on . In this video, Alokkumar Jha, PhD, MSc, BE, spoke with Healio about key presentations from the American ...
Seeking Alpha

Vigil Neuroscience Announces Multiple Presentations on Lead Indication ALSP at the 2023 American Academy of Neurology Annual Meeting

WATERTOWN, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (VIGL) (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the ...
Seeking Alpha

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
Nasdaq

Cytokinetics Announces Presentation of Results From FORTITUDE-ALS at the American Academy of Neurology 71st Annual Meeting

SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that results from FORTITUDE-ALS (Functional Outcomes in a Randomized Trial of ...
Business Wire

Adamas Announces Two Presentations for the American Academy of Neurology 73 rd Annual Meeting

EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by ...
Business Wire

Presentation at American Neurological Association Congress Confirms Potential of GeNeuro’s Novel anti-HERV-K Antibody for Amyotrophic Lateral Sclerosis

Dr. Avindra Nath, Clinical Director of National Institute of Neurological Disorders and Stroke (NINDS), presented novel pre-clinical results of the Amyotrophic lateral sclerosis (ALS) research program ...